Investor profile
HealthCap has backed 15 European tech companies across 21 funding rounds between 2005 and 2026, joining rounds totalling €496M. Most active in Healthtech. Data as of 6 Aug 2026.
Also recorded as: Health Cap
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemab Therapeutics | Denmark | 1 | €127M |
| Precirix | Belgium | 1 | €80M |
| BONESUPPORT | Sweden | 3 | €54M |
| Vivet Therapeutics | France | 1 | €38M |
| OxThera | Sweden |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Precirix | Series B | €80M | 2022-03 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |
| BONESUPPORT |
| 2 |
| €35M |
| GenSight Biologics | France | 1 | €32M |
| Doctrin | Sweden | 3 | €31M |
| Priothera Limited | Ireland | 1 | €30M |
| Ariceum Therapeutics | Germany | 1 | €25M |
| CurifyLabs | Finland | 1 | €12M |
| HelloBetter | Germany | 2 | €10M |
| Positrigo | Switzerland | 1 | €7.5M |
| Oncorena | Sweden | 1 | €6.4M |
| Oncos Therapeutics | Finland | 1 | €5.0M |
| Elsa Science | Sweden | 1 | €3.9M |
| Growth/Late |
| €33M |
| 2016-10 |
| GenSight Biologics | Series B | €32M | 2015-07 |
| Priothera Limited | Series A | €30M | 2020-10 |
| Ariceum Therapeutics | Series A | €25M | 2022-06 |
| OxThera | Other | €18M | 2005-07 |
| OxThera | Other | €17M | 2007-06 |
| BONESUPPORT | Growth/Late | €13M | 2011-06 |
